Sort   by:  
 Page size 
ProteomicsGlioma classification based on mass spectrometry imaging to spatially resolved proteomic and clinical data open a new stratification of patients for a more adaptated treatment
Gliomas represent 80% of all malignant cerebral tumors and are classified within different malignity grade. Glioblastoma, the most aggressive group, represent more than half of all gliomas but remain a heterogeneous group. Indeed, patient survival can reach from several months to a few years after s...
ORGANISM(S): Homo sapiens (Human) 
2023-03-10 | PXD016165 | Pride
Classification Glioma Proteomic Maldi 
Sort   by:  
 Page size